Provention Bio shares tumble as U.S. FDA declines to approve diabetes drug
By Amruta Khandekar (Reuters) -The U.S. health regulator on Tuesday declined to approve Provention Bio
By Amruta Khandekar (Reuters) -The U.S. health regulator on Tuesday declined to approve Provention Bio